Previous 10 | Next 10 |
Recent news releases related news releases and press releases from 04/02/24 07:30:52 on US and Canada Markets.
TAMPA, Fla., April 02, 2024 (GLOBE NEWSWIRE) -- Kforce Inc. (NASDAQ: KFRC), a provider of professional staffing services and solutions, will release first quarter results post-market on Monday, April 29, 2024, followed by a conference call at 5:00 pm ET to discuss the results. The dial-in number ...
Origin Agritech Provides First Half Revenue Forecast and Updates Advancements in Hybrids and GMO Development PR Newswire Estimated Revenue Growth of 30-40% in the First Half of FY 2024 Two New Hybrids Completed National Trials and Four GMO Corn Hybrids Currently in Nat...
EDMONTON, Alberta, April 02, 2024 (GLOBE NEWSWIRE) -- Papa Johns announced today the limited-time release of its brand-new Crispy Cuppy ‘Roni menu platform. This launch gives consumers three craveable ways to enjoy the premium, new cupping pepperonis from Papa Johns. “Weȁ...
Lincoln Electric Holdings, Inc., (the “Company”) (Nasdaq: LECO) announced today that it will release its first quarter 2024 results on Thursday, April 25, 2024, prior to market open. An investor conference call and webcast will take place at 10:00 a.m. (ET) later that day. The e...
Jazz Pharmaceuticals Completes Zanidatamab Biologics License Application for Previously Treated HER2-Positive Metastatic Biliary Tract Cancer PR Newswire Submission based on data from Phase 2b HERIZON-BTC-01 trial, which met its primary endpoint in patients receiving zanid...
CME Group Reports March and Q1 2024 Market Statistics PR Newswire Record Q1 U.S. Treasury futures and options ADV of 7.8 million contracts Record Q1 Options ADV of 5.9 million contracts CHICAGO , April 2, 2024 /PRNewswire/ -- CME Gro...
TORONTO, April 02, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. , (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that three additional clinical sites in Turkey have joined the Phase II trial for LSALT peptide targeting the prevent...
TORONTO, April 02, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. , (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that three additional clinical sites in Turkey have joined the Phase II trial for LSALT peptide targeting the prevent...
Orexo announces that the condition for early redemption of its existing bonds has been fulfilled PR Newswire UPPSALA, Sweden , April 2, 2024 /PRNewswire/ -- On March 13 , 2024, Orexo AB (publ), (" Orexo " or the " Company ") (STO:ORX) ...
VENICE, FL / ACCESSWIRE / April 2, 2024 / Conservative Broadcast Media & Journalism (OTC PINK:CBMJ) reveals in its recently filed annual report significant improvements to its Income Statement and Balance Sheet. It is also pleased to announce that it has successfully launched "Patriot Elite"...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
21.31%Change Percent:
Kiniksa Pharmaceuticals Ltd. Company Name:
KNSA Stock Symbol:
NASDAQ Market:
kiniksa.com Website: